Bugging the bugs: Novel approaches in the strategic management of resistant Staphylococcus aureus infections

Clinical Infectious Diseases

Volumn 45, Issue SUPPL. 3, 2007, Pages

  Kollef, Marin H ^a,b  

^a BARNES JEWISH HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; COMMUNICABLE DISEASE; EDITORIAL; HOSPITAL INFECTION; HYGIENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UNITED STATES;

ANTI-BACTERIAL AGENTS; HUMANS; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; UNITED STATES; VIRULENCE;

EID: 34548474520     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/519475     Document Type: Editorial

References (12)

1. Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Available at: http://www.cdc.gov/ncidod/ dhqp/pdf/nnis/2004NNISreport.pdf. Accessed 16 February 2007.
2. Centers for Disease Control and Prevention. Campaign to prevent antimicrobial resistance in healthcare settings: why a campaign? Available at: http://www.cdc.gov/drugresistance/healthcare/problem.htm. Accessed 16 February 2007.
3. Infectious Diseases Society of America. Bad bugs, no drugs: as antibiotic discovery stagnates... a public health crisis brews. Available at: http://www.idsociety.org/pa/IDSA_Paper4_final_web.pdf. Accessed 1 March 2007.
4. Styers D, Sheehan DJ, Hogan P, Sahm DF. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob 2006; 5:2.
5. Kollef MH, Micek ST. Methicillin-resistant Staphylococcus aureus: a new community-acquired pathogen? Curr Opin Infect Dis 2006; 19:161-8.
6. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003; 290:2976-84.
7. Gonzalez BE, Rueda AM, Shelburne SAI, Musher DM, Hamill RJ, Hulten KG. Community-associated strains of methicillin-resistant Staphylococcus aureus as the cause of healthcare-associated infection. Infect Control Hosp Epidemiol 2006; 27:1051-6.
8. Micek ST, Heuring TJ, Hollands JM, Shah RA, Kollef MH. Optimizing antibiotic treatment for ventilator-associated pneumonia. Pharmacotherapy 2006; 26:204-13.
9. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005; 128:3854-62.
10. Centers for Disease Control and Prevention. Campaign to prevent antimicrobial resistance in healthcare settings: 12 steps to prevent antimicrobial resistance among hospitalized adults. Available at: http://www.cdc.gov/drugresistance/healthcare/ha/12steps_HA.htm. Accessed 16 February 2007.
11. Schramm GE, Johnson JA, Doherty JA, Micek ST, Kollef MH. Methicillin-resistant Staphylococcus aureus sterile-site infection: the importance of appropriate initial antimicrobial treatment. Crit Care Med 2006; 34:2069-74.
12. Shorr AF, Jackson WL, Lipman J. Making the wrong choice: Consequences for patients with infections due to methicillin-resistant Staphylococcus aureus. Crit Care Med 2006; 34: 2239-41.